This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Kanoncure, Inc., National University Corporation Tottori University, Tottori University. Active years: 2022-2025.
Company Filing History:
2 out of 4 
1 out of 4 
1 out of 61 
Years Active: 2022-2025
Title: Shinya Kunita: Innovator in Cancer Therapeutics
Introduction
Shinya Kunita is a prominent inventor based in Yonago, Japan. He has made significant contributions to the field of cancer therapeutics, focusing on innovative solutions for malignant tumors and fibrosis. With a total of 2 patents, his work is paving the way for new treatment options in oncology.
Latest Patents
Kunita's latest patents revolve around the inhibitory effects of low molecular weight compounds on cancer and fibrosis. He has developed a novel therapeutic drug that targets malignant tumors and cancer stem cells. This drug includes at least one compound selected from a specific group of formulas, along with its salts or solvates. Additionally, his research extends to therapeutic drugs for fibrosis, utilizing similar compounds to combat this condition effectively.
Career Highlights
Throughout his career, Shinya Kunita has worked with notable organizations such as Kanoncure, Inc. and Tottori University. His experience in these institutions has allowed him to collaborate with leading experts in the field, enhancing his research and development efforts.
Collaborations
Some of his notable coworkers include Goshi Shiota and Noriko Itaba. Their collaborative efforts have contributed to the advancement of therapeutic strategies in cancer treatment.
Conclusion
Shinya Kunita's innovative work in cancer therapeutics highlights his commitment to improving patient outcomes. His patents and collaborations reflect a dedication to advancing medical science and providing new hope for those affected by cancer and fibrosis.